Eric Adler

Insider Reports History

Entity
Individual
Location
C/O Lexeo Therapeutics, Inc., 345 Park Avenue South, 6 Th Floor, New York, NY
Signature
/s/ Jenny Robertson, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Eric Adler:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Lexeo Therapeutics, Inc. Chief Medical Officer Common Stock 26.9K $355K $13.22 Feb 2, 2024 Direct
Lexeo Therapeutics, Inc. Chief Medical Officer Employee Stock Option (right to buy) 161K Feb 2, 2024 Direct

Insider Reports Filed by Eric Adler

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LXEO Lexeo Therapeutics, Inc. Feb 2, 2024 2 $0 4 Feb 6, 2024 Chief Medical Officer
LXEO Lexeo Therapeutics, Inc. Nov 2, 2023 0 $0 3 Nov 2, 2023 Chief Scientific Officer